![](/img/cover-not-exists.png)
A Phase II Trial of Brentuximab Vedotin (BV) and Lenalidomide (Len) in Relapsed and Refractory (r/r) Cutaneous (CTCL) and Peripheral (PTCL) T-Cell Lymphomas; Preliminary Results
William, Basem, Huang, Ying, Brammer, Jonathan, Chung, CatherineVolume:
19
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.07.384
Date:
September, 2019
File:
PDF, 92 KB
english, 2019